First in Human Dose Ascending, Randomized, Placebo-Controlled Clinical Trial to Assess Tolerability and Pharmacokinetics of ApTOLL in Healthy Volunteers
Latest Information Update: 18 Mar 2022
At a glance
- Drugs ApTOLL (Primary)
- Indications Stroke
- Focus Adverse reactions; First in man; Pharmacokinetics
- Sponsors aptaTargets
- 09 Feb 2021 New trial record